Call for Applications: Eye Health Innovation Accelerator by Villgro Africa

Entrepreneurs and startups across Sub-Saharan Africa now have a unique opportunity to transform eye care on the continent. Villgro Africa has officially opened applications for the 2026 cohort of its Villgro Africa Eye Health Innovation Accelerator Program, a targeted initiative designed to identify, strengthen, and scale the most promising technology-driven solutions that make quality eye care more accessible, affordable, and effective in low- and middle-income countries (LMICs).

Supported by a strategic partnership with The Fred Hollows Foundation, the program combines intensive technical assistance, hands-on business support, deep market-access facilitation, and catalytic investment to help ventures move from early traction to regional and pan-African scale.

What is Villgro Africa?

Villgro Africa is one of the continent’s leading incubators and early-stage investors dedicated to health and life-sciences innovation. Based in Nairobi and active across Sub-Saharan Africa, the organization has built a strong track record of backing high-impact entrepreneurs who tackle some of Africa’s toughest public health challenges. Since its inception, Villgro Africa has supported dozens of startups with mentorship, funding, and market-access strategies that turn promising ideas into sustainable enterprises capable of serving millions.

With a sharp focus on investment readiness and systems-level change, Villgro Africa works closely with global foundations, development partners, governments, and corporate players to create pathways for innovations to reach the last mile. Its portfolio companies have collectively raised tens of millions of dollars in follow-on capital and positively impacted the lives of hundreds of thousands of patients across the region.

Program Focus and Priority Areas

The Eye Health Innovation Accelerator is laser-focused on technology-enabled ventures that dramatically expand access to screening, diagnosis, treatment, and ongoing management of vision impairment and blindness throughout LMICs.

Key innovation categories the program actively seeks include:

• Hybrid “brick-and-click” models that blend physical clinics with digital outreach for primary and specialist eye care
• Artificial intelligence and machine-learning tools for automated detection, triage, and decision support
• Portable, community-level screening devices and low-cost diagnostic hardware
• Teleophthalmology platforms, remote consultation systems, and digital vision-screening apps
• Electronic health record (EHR) systems, data dashboards, and workflow automation tailored to eye-care providers
• Affordable assistive technologies and vision aids powered by smart design or digital features

Who Should Apply? (Eligibility Snapshot)

The program is looking for African-founded or African-led startups that already have real-world validation and are ready to scale. Core requirements include:

1. Legal registration in any Sub-Saharan African country
2. At least one founder or C-level executive who is a resident of an African nation
3. A working, technology-enabled product or service that directly addresses major eye-health challenges
4. Clear evidence of customer adoption, active pilots, partnerships, or early revenue
5. A credible path to scale across multiple LMICs
6. Commitment to responsible innovation, patient data protection, and alignment with national eye-health strategies

Selection Criteria at a Glance

Applications will be evaluated against seven core dimensions:

• Depth of health impact and evidence of improved access, quality, or affordability
• Technical excellence and relevance to real clinical or community needs
• Market traction (users, revenue, pilots, or letters of intent)
• Scalability and adaptability to diverse LMIC settings
• Strength and readiness of the founding and leadership team
• Ability to effectively deploy catalytic capital and attract follow-on investment
• Alignment with national eye-health priorities and public-sector integration potential

What Selected Ventures Receive

Successful applicants will join an intensive, high-touch program that includes:

• Tailored technical assistance from world-class eye-health clinicians, digital health experts, and business strategists
• Eligibility for non-dilutive or convertible seed grants ranging from $100,000 to $250,000, plus introductions to follow-on investors
• In-person bootcamp, peer-learning retreats, and demo days
• One-on-one mentorship from ophthalmologists, health-system leaders, and seasoned entrepreneurs
• Support in navigating regulatory approvals, government partnerships, and public procurement pathways
• Warm introductions to hospital networks, NGOs, research institutions, and referral systems across Africa and beyond

Expected Outcomes by Program End

By the close of the accelerator, participating companies typically achieve:

• Sharply refined, investment-ready business models and financial projections
• Secured seed capital and active conversations with co-investors
• Signed MOUs or commercial agreements with health facilities and distribution partners
• Clear go-to-market strategies for at least three additional African markets

How to Apply

Interested teams should prepare and submit:

• A concise company pitch deck
• A short 2-minute video pitch or product demo (strongly encouraged but optional)
• The official online application form
• Additional documentation as requested during the screening phase

Applications are now live. Early submission is recommended, as the program receives high interest every cycle.

Who Is Not Eligible?

The accelerator will not consider: pure biotech R&D projects, pre-revenue concepts without market validation, academic prototypes that have never been deployed, donor-only models with no path to commercial sustainability, or solutions that fall outside eye health.

For full details, eligibility checker, and the official application portal, visit the Villgro Africa Eye Health Innovation Accelerator 2026 webpage today.

This is your chance to put your vision-saving innovation in front of the mentors, funders, and health-system partners who can help take it continent-wide. Don’t miss the 2026 cohort—apply now!